GIVPY yields 39.34% · JNJ yields 2.13%● Live data
📍 GIVPY pulled ahead of the other in Year 1
Combined, GIVPY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GIVPY + JNJ for your $10,000?
Grupo de Inversiones Suramericana S.A. operates in the financial services, industry, and corporate venture sectors in Colombia and internationally. The company offers general and life insurance, as well as reinsurance; pension, saving, investment, and asset management services; investment funds; annuities; severance pay and complementary services; health plans; occupational hazards; and business, consumer, insurance, investment, offshore, private, and government banking, as well as treasury products. It also produces cement, concrete, and aggregates; provides processed foods, such as cold cuts, confectionery, chocolates, coffees, ice cream, pasta, and consumer foods; and offers power generation and distribution, real estate, road and airport concessions, and business support services. In addition, the company provides a technological solution to manage human talent information for companies; a digital marketplace for mortgage sector; a platform for engagement, marketing, sale, and administration of financial products; a health technology platform; tools to manage prevention and wellbeing programs; web and mobile platform based on artificial intelligence; platform for on-demand insurance; and risk capital fund for early-stage and growing technology companies. Further, it offers integrated information, technology, and knowledge solutions; and residential, functional conditioning, and rehabilitation services for the elderly. Additionally, the company provides data processing and leasing computer equipment, consultancy and advisory, promotion, and marketing services; management consultancy services; medical, paramedical, dental, and diagnostic aid services; risk management, telecommunication, and outsourcing services; and vehicle inspection, repair, purchase, and selling services, as well as acts as securities brokers; and purchases and sells securities. The company was incorporated in 1997 and is headquartered in Medellin, Colombia.
Full GIVPY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.